This Insight Pharma Report:
This research begins by considering definitions for backup compounds, reviewing key literature references that present expert views on the topic, and presenting case studies that describe how medicinal chemists approach design and selection of backup compounds. Backup strategies currently in effect, and the types of issues companies consider when deciding whether to designate and advance backup compounds once a drug candidate is selected, are examined. These issues include the necessity for backup compounds; whether backup strategies are ad hoc or policy-based; whether to advance backups based on the same or different chemical scaffold as the prototype; how to best deal with addressing backup compound-related questions before a prototype has advanced to the stage where information needed for such decision-making becomes available; and the role of biomarkers and backup compounds in drug repositioning.
Get your copy of this report @ http://www.reportsnreports.com/reports/157192-backup-compound-strategies-commercial-and-tactical-considerations-overview.html
Released On: 9/3/2012
Views: 3192
Released On: 8/31/2012
Views: 3917
Released On: 8/27/2012
Views: 2203
Released On: 8/23/2012
Views: 3063
Released On: 8/23/2012
Views: 2107
Released On: 8/21/2012
Views: 2783
Released On: 8/16/2012
Views: 3434
Released On: 8/16/2012
Views: 2036
Released On: 8/16/2012
Views: 4279
Released On: 8/14/2012
Views: 2167
Released On: 8/14/2012
Views: 1862